DEA Change In Opioid Policy Created Confusion, Judge Hears

By Bonnie Eslinger (June 7, 2022, 11:58 PM EDT) -- The U.S. Drug Enforcement Administration created "confusion" internally and with prescription drug distributors when it began requiring new suspicious order monitoring systems as opioid use surged around 2006, a San Francisco judge heard Tuesday in recorded testimony played during a bellwether opioid bench trial....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!